000915 logo

Shandong Wit Dyne Health
000915

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CN¥7.74B
EV
CN¥6.05B
Shares Outstanding
234.33M
Beta
0.09
Industry
Drug Manufacturers - Specialty & Generic

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
-
Number of Analysts
0
P/E 2025E
13.88x
P/Revenue 2025E
3.42x

Historical 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Forecasted 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Margins & Returns

Gross Margin 2025E
83.50%
Net Profit Margin 2025E
24.61%
ROE 2025E
19.17%
ROCE 2024
17.50%

Dividends

DPS 2025E
CN¥1.85
Payout Ratio 2025E
77.73%
Div. Yield 2025E
5.41%
DPS Last 3Y CAGR

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Shandong Wit Dyne Health Co.,Ltd.

gainify
000915 logo

Shandong Wit Dyne Health Co.,Ltd.

000915

Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, licorice zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gel, roxithro...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Yang, Jie

Employees

1,759

IPO Date

1999-06-09

Headquarters

Walter Plaza, No. 17703, 4th Floor, Jingshi Road, Jinan, Shandong Province, 250061, China

📊 Stock Price & Performance

The last closing price of Shandong Wit Dyne Health (000915) is CN¥33.04, reflecting a +0.12% change from the prior session. Last updated: January 1, 2026 at 2:03 AM Eastern Time

Review the recent 000915 stock performance trends:Past 1 Month: Shandong Wit Dyne Health (000915) shares have -2.97%.Past 3 Months: The stock has +5.56%.Past 6 Months: 000915 shares have -6.53%. Last updated: January 1, 2026 at 12:05 AM Eastern Time

Over the last year, Shandong Wit Dyne Health (000915) has established a 52-week price range between a high of CN¥36.70 and a low of CN¥25.17. This metric is essential for assessing the stock's annual volatility. Last updated: January 1, 2026 at 12:05 AM Eastern Time

Shandong Wit Dyne Health (000915) is considered a low volatility stock. It has a beta of 0.09, which means it typically moves 0.09 times as much as the broader market. Over the past 52 weeks, 000915 has traded within a CN¥25.17 – CN¥36.70 range. Last updated: January 1, 2026 at 12:05 AM Eastern Time

A CN¥1,000 investment in Shandong Wit Dyne Health 5 years ago, when the stock was trading around CN¥23.39, would be worth approximately CN¥1412.41 today, based solely on share price performance (excluding dividends). This represents a total return of 41.24% over the period, equivalent to a compound annual growth rate (CAGR) of 7.15%. Past performance reflects historical price movements only and does not imply future results. Last updated: January 1, 2026 at 12:05 AM Eastern Time

💰 Financial Metrics & Reports

The current Shandong Wit Dyne Health (000915) market capitalization is approximately CN¥7.74B, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Shandong Wit Dyne Health's market cap fluctuates with changes in its share price and share count. Last updated: January 1, 2026 at 12:05 AM Eastern Time

In the most recently reported quarter, Shandong Wit Dyne Health (000915) generated CN¥432.12M in revenue, representing a +93.28% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: January 1, 2026 at 3:41 AM Eastern Time

In the most recently reported fiscal year, Shandong Wit Dyne Health (000915) generated net income of CN¥515.59M, compared with CN¥585.26M in the prior fiscal year, representing a -11.90% year over year change. For the upcoming fiscal year, analyst consensus currently estimates net income of CN¥557.00M. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: January 1, 2026 at 3:41 AM Eastern Time

According to its latest quarterly filing, Shandong Wit Dyne Health (000915) reported EBITDA of CN¥160.83M, representing a +123.70% year over year change. EBITDA is a non-GAAP measure and does not account for depreciation, amortization, interest expense, taxes, or capital expenditures. As a result, it should be considered alongside other financial metrics when assessing operating performance. Actual results may differ from estimates as company-specific or macroeconomic conditions evolve. Last updated: January 1, 2026 at 3:41 AM Eastern Time

Based on the latest available data, Shandong Wit Dyne Health (000915) is currently trading at a last twelve months (LTM) P/E ratio of 13.87x. The P/E ratio reflects how much investors are willing to pay today for a dollar of earnings and can vary meaningfully over time due to changes in profitability, growth expectations, margin outlook, and earnings volatility. Last updated: January 1, 2026 at 3:41 AM Eastern Time

📅 Earnings & Dividends

In the most recently reported quarter, Shandong Wit Dyne Health (000915) revenue was CN¥432.12M. Earnings per share (EPS) for the quarter were CN¥0.30. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: January 1, 2026 at 3:41 AM Eastern Time

📈 Analyst Information

Based on the latest available analyst coverage, Shandong Wit Dyne Health (000915) currently carries a Outperform consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: January 1, 2026 at 3:41 AM Eastern Time

Like other publicly traded stocks, Shandong Wit Dyne Health (000915) shares are bought and sold on stock exchanges such as SZSE and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Shandong Wit Dyne Health (000915) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

ℹ️ Company Information

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add 000915 to your watchlist.

Shandong Wit Dyne Health trades under the ticker symbol 000915 on the SZSE stock exchange. The ticker 000915 is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.

As of the most recently reported period, Shandong Wit Dyne Health (000915) employs approximately 1,759 people worldwide. Reported employee figures may fluctuate over time due to hiring activity, restructuring, automation initiatives, or changes in business strategy. Headcount data is typically disclosed in company filings and reflects full-time employees unless otherwise stated. Last updated: January 1, 2026 at 12:05 AM Eastern Time

Shandong Wit Dyne Health (000915) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Shandong Wit Dyne Health (000915) stock peers based on overlapping products, services, and competitive dynamics:China Resources Boya Bio-pharmaceutical Group (300294)Shanghai Haoyuan Chemexpress (688131)Micro-Tech (Nanjing) (688029)Gushengtang Holdings (2273)Tasly Pharmaceutical Group (600535)Zhejiang Jiuzhou Pharmaceutical (603456)Autobio Diagnostics (603658)Jiangsu Hengrui Pharmaceuticals (600276)Asymchem Laboratories (Tianjin) (002821)Amoy Diagnostics (300685) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Shandong Wit Dyne Health.

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2026 Gainify. All rights reserved.